Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
2,3-Oxidosqualene cyclase (OSC) is a key enzyme in the biosynthesis of sterols and triterpenes. It catalyzes the cyclization of 2,3-oxidosqualene into various polycyclic products such as lanosterol and cycloartenol, which are precursors for cholesterol and other sterols in animals, fungi, and plants. OSC's activity represents a crucial step in the formation of the steroid nucleus. Inhibitors targeting OSC are being explored for hypocholesterolemic effects as well as antifungal or phytotoxic applications.
Inhibition of 2,3-oxidosqualene cyclization
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 2,3-Oxidosqualene Cyclase (OSC).